<차례>

요약문 / 1

제1장 연구개요 / 5

1. 연구 필요성 및 목적 ··················································································· 5

2. 국내외 관련 정책 및 제도 ········································································ 10

3. 연구 수행 체계 ························································································· 24

4. 연구내용 및 방법 ···················································································· 25

제2장 만성질환 건강관리 어플리케이션 활용 모델 개발 / 31

1. 건강관리 모바일 어플리케이션 활용 중재연구에 대한 문헌 고찰 ·············· 31

2. 국내 주요 건강관리 모바일 어플리케이션 ················································· 40

3. 일차의료기관 방문 만성질환자 대상 건강관리 어플리케이션 활용 모델 ···· 44

제3장 만성질환 건강관리 어플리케이션 효과 분석 / 50

1. 사업 운영 및 진행 현황 ············································································ 50

2. 사업 효과 분석 ························································································· 58

제4장 Focus􀀁 Group􀀁 Interview􀀁 및 전문가 자문 회의 / 76

제5장 만성질환 건강관리 어플리케이션 활용 방안 및 정책제안 / 84

1. 만성질환 건강관리 어플리케이션 활용 방안 ············································ 84

2. 만성질환 건강관리 어플리케이션 활용 정책 제안 ······································ 89

참고문헌 / 94

부록 / 99

1. 연구 동의서 ···························································································· 101

2. 참여 의원 List ························································································ 103

3. 설문지 ····································································································· 104

<목차>

part1 2019 외국인환자 유치실적 조사개요 / 1

part2 2019 외국인환자 유치실적 주요 통계 / 5

part3 주요 요인별 통계 / 27

가. 국가별 유치현황 ··································································································· 28

나. 지역별 유치현황 ··································································································· 65

다. 의료기관 유형별 유치현황 ················································································· 124

부 록 / 143

<차 례>

제1장 연구개요 / 1

1. 연구배경 및 목적·································································································· 1

2. 연구내용 및 방법 ································································································· 2

제2장 스마트병원의 등장배경 / 4

1. 국내외 보건의료 환경의 변화················································································ 4

2. 의료서비스 패러다임의 변화 요구······································································· 13

제3장 스마트병원의 개념 및 기대효과 / 16

1. 스마트병원의 개념······························································································· 16

2. 디지털 병원과의 차이점 ····················································································· 20

3. 스마트 헬스케어에서의 스마트병원의 역할·························································· 23

4. 스마트병원의 개념 정립 ····················································································· 25

5. 스마트병원의 기대효과························································································ 29

제4장 주요국의 스마트병원 정책 추진 동향 / 32

1. 싱가포르·············································································································· 32

2. 중국····················································································································· 34

3. 일본····················································································································· 39

4. 호주····················································································································· 40

5. 영국····················································································································· 41

6. 덴마크················································································································· 43

7. 한국 ··················································································································· 44

8. 시사점 ················································································································ 45

ii

제 5장 국내 의료기관들의 스마트화 움직임 / 47

1. 주요 의료기관들의 스마트병원 추진 전략 ························································ 47

2. 디지털 솔루션 도입 실패 사례 ·········································································· 58

3. 시사점 ················································································································ 64

제6장 의료기관의 당면 문제 / 65

1. 의료기관의 당면 문제 ························································································ 65

2. 도입 가능한 스마트화 요소················································································· 99

3. 의료기관들의 스마트화 저해요인······································································· 118

제7장 스마트병원 관련 기술 동향 및 국내 기업 현황 / 127

1. 글로벌 스마트병원 시장 현황············································································ 127

2. 스마트병원 관련 주요 기술의 서비스 적용 사례 ············································· 129

3. 스마트화 요소 관련 국내기업 현황 및 문제점·················································· 135

제8장 스마트병원 육성 방안 / 149

1. 스마트병원 육성을 위한 고려사항····································································· 149

2. 스마트병원 육성 방안 ······················································································ 158

제9장 요약 및 정책제언 / 171

참고문헌 / 177

이 가이드라인은

외국인환자를 유치하려는 의료기관 및 유치업자가

온라인 의료광고를 할 경우, 준수해야 할 사항을

주요 위반유형과 사례 중심으로 안내하고 있습니다.

이 가이드라인의 부당한 표시･광고 유형은

외국인환자유치 온라인 의료광고에서 발생하기 쉬운 주요 위반유형을

예시한 것으로, 이 가이드라인에 열거되지 아니한 행위라고 해서

부당한 표시･광고에 해당되지 않는 것은 아닙니다.

외국인환자유치 온라인 의료광고 내용에 관한 사항은

보건복지부, 한국보건산업진흥원,

한국인터넷광고재단에 문의하시기 바랍니다.

또한, 외국인환자 유치기관의 등록 등에 관한 사항은

관할 시･도로 문의하시기 바랍니다.

<목차>

I. 가이드라인 개요 - 1

II. 주요 위반유형 및 사례 - 7

1. 주요 위반유형 - 9

2. 주요 위반사례 - 11

부록 - 33

<목차>

1. 개요 5

1-1. 보건의료기술의 정의 및 범위 5

1-2. 보건의료기술표준분류체계 특성 및 구성 7

2. 분석범위 및 방법 9

3. 보건의료 R&D 정부 투자 현황 13

4. 보건의료기술표준분류체계 기준 투자현황 분석 16

4-1. 질환별 16

4-2. 연구행위 및 산출물별 18

4-3. 의약품 제품개발 단계별 20

5. 사회경제적 지표통계와의 비교 분석 22

5-1. 사회경제적 지표통계와 비교 분석 의미 22

5-2. 진료비 통계, 질병부담(GBD)과 비교분석 23

5-3. 사망원인질환에 대한 투자분석 28

[부록] 39

<차례>

제1장 서론 / 1

1. 연구 배경 및 목적 ································································································· 1

2. 연구의 범위 및 방법 ····························································································· 3

3. 기대효과 및 활용방안 ···························································································· 4

제2장 글로벌 산업 동향 / 5

1. 산업의 정의와 범위 ······························································································· 5

2. 촉진·억제·기회요인 ································································································ 7

3. 주요 산업 동향 ···································································································· 14

제3장 주요 선진국 제도 동향 및 비즈니스 모델 / 20

1. 국가별 의료기기 규제 동향 ················································································· 20

2. 보험 적용 동향 ···································································································· 29

3. 비즈니스 모델 ······································································································ 33

제4장 중국 산업·제도 동향 / 35

1. 산업현황 ·············································································································· 35

2. 정책 및 제도 ······································································································· 41

5장 글로벌 업체 동향 / 49

1. 글로벌 업체 동향 ································································································ 49

2. 중국 업체 동향 ···································································································· 53

제6장 결 론 / 60

<목차>

I. 서론 1

1. 연구의 배경 및 목적 1

2. 연구의 방법 5

II. 재난적 감염질환의 백신개발 등에 관한 특별법 제정 방안 6

1. 들어가며 6

2. 감염병 대응을 위한 현행 제도 고찰 8

3. 신종 감염병 발생 시 대응 동향 23

4. 코로나코로나19 대응 외국 사례 35

5. 특별법 제정의 필요성필요성-신종 감염병에 대응하기 위한 현행 법체계의 한계와 문제점 40

6. 특별법 입법제안 46

III. 보건의료 R&D 거버넌스 재정립 및 보건산업 육성 91

1. 보건의료 R&D 거버넌스 개요 91

2. 보건의료 R&D 거버넌스의 문제점 및 재정립 필요성 108

3. 보건의료 R&D 거버넌스 기구의 개편 방안방안(진흥법 제제6조 관련관련) 117

4. 보건산업 육성 법제의 개선방안 186

5. 보건의료기술 진흥법 개정안 221

6. [보론보론] 해외 보건의료 R&D 거버넌스 분석 235

IV. 참고문헌 256

[별첨별첨] 특별법특별법(가칭 「재난적 감염질환 백신개발 등에 관한 특별법」 초안 1